Β-cell dysfunction in metabolic syndrome and type 2 diabetes: mechanism of development and possibilities for correction
Normal β-cell physiology should be maintained throughout life. However, it is negatively affected by various factors. Metabolic syndrome is often a predisposing factor for the development of prediabetes and type 2 diabetes mellitus. The main component of MS is visceral obesity, which is accompanied by a number of disorders: insulin resistance, oxidative stress, inflammation, increased levels of free fatty acids. All of these factors lead to impaired β-cell function and/or cell death. β-cell dysfunction and reduction in their mass is one of the causes of type 2 diabetes. Maintaining their secretory function and protecting them from destruction will improve the compensation of patients with type 2 diabetes and slow down its progression. Therefore, antidiabetic therapy should be aimed at preserving β-cells and maintaining their mass. Drugs that affect insulin resistance, drugs with incretin effects, and inhibitors SGLT-2 have a positive effect on pancreatic islet cells.
Authors
- Lyudmila A. Sharonova (ORCID: https://orcid.org/0000-0001-8827-4919)
- E. V. Treneva (ORCID: https://orcid.org/0000-0003-0097-7252)
- О В Косарева (ORCID: https://orcid.org/0009-0006-4531-9682)
- Yu. A. Dolgikh (ORCID: https://orcid.org/0000-0001-6678-6411)
- P. Ya. Merzlova (ORCID: https://orcid.org/0009-0004-6243-6528)
- Dmitrii P. Kurmaev (ORCID: https://orcid.org/0000-0003-4114-5233)
Institutions
- Samara State Medical University (RU)
Publication Details
- Journal
- Экспериментальная и клиническая гастроэнтерология
- Published
- 2026-11-18
- DOI
- https://doi.org/10.31146/1682-8658-ecg-248-4-173-180
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00